<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/19A99966-821F-4E07-95BA-10C200B2837E"><gtr:id>19A99966-821F-4E07-95BA-10C200B2837E</gtr:id><gtr:name>Vueklar Cardiovascular Limited</gtr:name><gtr:address><gtr:line1>5TH FLOOR , 125 PRINCES STREET</gtr:line1><gtr:city>EDINBURGH</gtr:city><gtr:postCode>EH2 4AD</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19A99966-821F-4E07-95BA-10C200B2837E" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>19A99966-821F-4E07-95BA-10C200B2837E</gtr:id><gtr:name>Vueklar Cardiovascular Limited</gtr:name><gtr:address><gtr:line1>5TH FLOOR , 125 PRINCES STREET</gtr:line1><gtr:city>EDINBURGH</gtr:city><gtr:postCode>EH2 4AD</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>24724.0</gtr:offerGrant><gtr:projectCost>32965.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/87164A59-48F7-43BA-BAA7-89DA458A6C18"><gtr:id>87164A59-48F7-43BA-BAA7-89DA458A6C18</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Boyd</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131316"><gtr:id>C69A1781-CEA6-4F54-AD40-68AA877F4FCC</gtr:id><gtr:title>Nanofibre-based materials for covered stents</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131316</gtr:grantReference><gtr:abstractText>VueKlar Cardiovascular is developing ground-breaking implants for the treatment of cardiovascular disease - a high value market. Up to 10 million patients a year are at risk of potentially fatal complications from the x-ray-based procedures relating to implants. VueKlar's patented implant technology removes complications, reduces fatalities, and reduces overall treatment costs by enabling non-invasive, non-toxic, x-ray-free procedures. This project will investigate the feasibility of an innovative nanoscale material and integration process.</gtr:abstractText><gtr:fund><gtr:end>2013-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2013-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>24724</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131316</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>